Centre raises alarm on adverse reaction caused by widely used life-saving beta blocker drugs

Concerned over the widely used life-saving beta blocker drugs causing adverse drug reactions, the government’s Indian Pharmacopoeia Commission (IPC) has issued an alert about the same.

An adverse drug reaction (ADR) is a harmful, unintended result caused by taking medication. ADRs may occur following a single dose or prolonged administration of a drug or may result from the combination of two or more drugs.

This is important as doctors widely prescribe the beta blocker medication to manage abnormal heart rhythms, prevent heart attack and migraine.

During a recently conducted analysis of Adverse Drug Reactions (ADRs), the commission found that the use of drugs such as metoprolol, propranolol, and atenolol can cause “Hypokalaemia”—a life-threatening condition due to potassium deficiency in the body.

Medically, the drugs metoprolol, propranolol and atenolol are used to treat hypertension in adults, functional heart disorders, migraine prophylaxis, cardiac arrhythmias, management of angina; essential and renal hypertension and other heart disorders.

“The analysis of adverse drug reactions from Pharmacovigilance Programme of India (PvPI) database revealed that beta blocker drugs (Metoprolol, Propranolol, and Atenolol) to cause adverse drug reaction,” stated IPC’s drug safety alert reviewed by Mint.

India’s beta-blocker market is currently valued at $11.06 billion and is expected to touch $15.08 billion by 2030.

India is one of the largest producers of quality medicines and has a robust pharmacovigilance system to monitor the safety profile of marketed pharmaceutical products.

“Healthcare professionals, patients or consumers are advised to closely monitor the possibility of the above ADR associated with the use of above suspected drug. If such a reaction is encountered, please report to the IPC,” it said.

IPC monitors adverse drug reactions among Indian population and helps the Central Drugs Standard Control Organization (CDSCO) take regulatory decisions for the safe use of medicines.

From March till December, around 13 different drugs were found to be showing adverse drug reaction as declared by IPC.

Related Posts

Restricted pills in car lead to shadow pharmacy empire stretching from Kanpur to Ludhiana.

Ludhiana: A local tip-off has cracked open a Punjab-UP pipeline where a failed pharmacist allegedly turned a licensed shop into a launchpad for seven lakh banned tablets — dragging hardware…

Gang which supplied Rs100 cr codeine cough syrup busted

Varanasi:  In a major operation, the Uttar Pradesh Food Safety and Drug Administration (UPFSDA) and police have busted one of the biggest rackets of codeine-based cough syrup, used as an…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Restricted pills in car lead to shadow pharmacy empire stretching from Kanpur to Ludhiana.

Restricted pills in car lead to shadow pharmacy empire stretching from Kanpur to Ludhiana.

Gang which supplied Rs100 cr codeine cough syrup busted

Gang which supplied Rs100 cr codeine cough syrup busted

Mahima Choudhary was ‘Lucky’ Cancer lurking behind her ‘Choli’ was caught early

Mahima Choudhary was ‘Lucky’ Cancer lurking behind her ‘Choli’ was caught early

Ujjain Set to Become Medical Device Manufacturing Hub: 11 Major Firms Pledge ₹600 Crore Investment, 1,700+ Jobs

Ujjain Set to Become Medical Device Manufacturing Hub: 11 Major Firms Pledge ₹600 Crore Investment, 1,700+ Jobs

Zydus Lifesciences gets USFDA nod for Leuprolide Acetate injection

Zydus Lifesciences gets USFDA nod for Leuprolide Acetate injection

Lupin launches generic injection in US with 180-day exclusivity

Lupin launches generic injection in US with 180-day exclusivity